Renasant Bio, Inc. — Form D
Renasant Bio, Inc. of BERKELEY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-14. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-07-14
- Form: D
- Accession: 0001231919-25-000109
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $30.0M
- Investors: 4
- Date of first sale: 2025-06-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-551569
Issuer
- Name: Renasant Bio, Inc.
- CIK: 0002075979
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2630 BANCROFT WAY #507, BERKELEY, CA, 94704
- Phone: 650-223-5603
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Kevin Bitterman | Director | Cambridge, MA |
| Evan Caplan | Director | Palo Alto, CA |
| Emily Conley | Director | Berkeley, CA |
| Anna French | Director | Watertown, MA |
| Natalie Holles | Director | Berkeley, CA |
| Charlotte McKee | Director | Berkeley, CA |
| Deborah Palestrant | Director | Berkeley, CA |
| Emily Conley | Executive Officer | Berkeley, CA |
| Thomas Gustafson | Executive Officer | Berkeley, CA |
| June Lee | Director | Berkeley, CA |
Other filings by this issuer (1)
More